Molecular pathogenesis of MLL-associated leukemias

Area of Science:

• Molecular Biology
• Hematology
• Oncology

Background:

• Chromosome translocations involving the MLL gene are frequent in infant and therapy-related acute leukemias.
• The normal MLL protein regulates gene expression, including Hox genes, through chromatin modulation.
• In leukemia, MLL gene fusions alter protein function, conferring leukemogenic properties to hematopoietic progenitors.

Purpose of the Study:

• To elucidate the mechanisms by which MLL gene fusions contribute to leukemogenesis.
• To identify the specific activities of fusion partners that drive MLL chimera function.
• To address unresolved questions regarding MLL fusion biology and leukemia etiology.

Main Methods:

• Analysis of MLL gene translocations and resulting chimeric proteins.
• Investigation of chromatin-modulating activities of MLL and its fusion partners.
• Studies on the impact of MLL chimeras on hematopoietic progenitor cells.

Main Results:

• MLL translocations create chimeric proteins that replace MLL's functional domains with those of fusion partners.
• These MLL chimeras possess self-renewing and leukemogenic activity in hematopoietic progenitors.
• Fusion partner activities, such as transactivation or oligomerization, contribute to the MLL chimera's oncogenic potential.

Conclusions:

• MLL gene fusions are critical drivers of specific acute leukemias.
• Understanding the biology of MLL chimeras and their fusion partners is essential for therapeutic development.
• Further research into MLL fusion etiology and target genes will inform novel treatment strategies.